Detalhe da pesquisa
1.
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.
Am J Hematol
; 99(7): 1240-1249, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586986
2.
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network.
Blood
; 139(5): 792-796, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871363
3.
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
Blood
; 126(11): 1346-56, 2015 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26186940
4.
Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation.
Haematologica
; 107(11): 2720-2724, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833301
5.
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.
Blood
; 122(20): 3521-32, 2013 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24014241
6.
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
J Hematol Oncol
; 17(1): 2, 2024 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38185663
7.
[Chronic lymphocytic leukemia]. / La leucémie lymphoïde chronique : mise au point.
Presse Med
; 48(7-8 Pt 1): 807-815, 2019.
Artigo
em Francês
| MEDLINE | ID: mdl-31447332
8.
The eukaryotic initiating factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemia.
Br J Haematol
; 156(4): 547-50, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21995271
9.
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.
Sci Adv
; 1(8): e1500221, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26601252
10.
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.
Cell Rep
; 11(9): 1446-57, 2015 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26004183
11.
Targeting glutamine uptake in AML.
Oncoscience
; 1(1): 1-2, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25593985